OraSure Technologies | OSUR - Debt


OraSure Technologies reported $782K in Debt for its fiscal quarter ending in June of 2024.





Debt Change Date
Agilent USD 3.35B 0 Dec/2025
AngioDynamics USD 6.3M 6.3M Feb/2025
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Bio Techne USD 200M 0 Jun/2026
Bio-Rad Laboratories USD 1.37B 7.8M Jun/2026
Bruker USD 1.82B 153.5M Jun/2026
Cerus USD 84.16M 791K Dec/2024
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Danaher USD 26.56B 8.07B Jun/2026
Dentsply International USD 2.33B 137M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Illumina USD 2.54B 9M Mar/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 16.24B 408M Jun/2026
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Mettler Toledo International USD 2.23B 76.47M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
OraSure Technologies USD 782K 465K Jun/2024
Quidel USD 2.87B 40.8M Mar/2026
Repligen USD 690.94M 144.36M Jun/2026
Revvity USD 3.35B 48.03M Mar/2026
STAAR Surgical USD 37.29M 1.06M Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Trinity Biotech USD 137.98M 37.22M Dec/2025
Waters USD 5.57B 4.08B Mar/2026